+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global HIV Diagnosis & Treatment Market 2022-2028

  • PDF Icon

    Report

  • 130 Pages
  • April 2022
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4450938
UP TO OFF until Dec 31st 2022

Global HIV diagnostics & treatment Market Size, Share & Trends Analysis Report By Test Type(Antibody Test, Viral Identification Assays, Cd4 Testing, Viral Load Testing, Early Infant Diagnostics) By Diagnostic Product (Assays, Kits & Reagents, Instruments, Software & Service, Others) By Treatment (Protease Inhibitors (Pis), Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis), Nucleoside Or Nucleotide Reverse Transcriptase Inhibitors (Nrtis), Entry Or Fusion Inhibitors, Integrase Inhibitors, Others) By End-User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Other End Users) Forecast 2021-2028


The global HIV diagnostics & treatment market is anticipated to grow at a substantial CAGR of 8.4% during the forecast period. The increasing awareness about this serious disease HIV and proper treatment and R&D is boosting the diagnostics & treatment market. Awareness leads to increase in testing. There 3 stages of HIV which include Acute HIV Infection, Chronic HIV Infection, Acquired Immunodeficiency Syndrome (AIDS). As it can be a deadly disease if not treated properly the peoples are doing test for their health. The governments and private companies is making aware the public about the HIV diseases , and its treatment. For instance, in 2020 according to WHO report US FDA approved new 5mg formulation of dolutegravir (DTG) for infants and children older than 4 weeks and weighing more than 3 kg. This drug will help treatment of HIV and save lives in many countries.


The global HIV diagnostics & treatment market is segmented based on test type, diagnostic product, treatment, and end-user. Based on test type the market is sub-divided into antibody tests, viral identification assays, cd4 testing, viral load testing, and early infant diagnostics. based on diagnostic product the market is segmented into assays, kits & reagents, instruments, software & service, and others (poc and single blood drop analyzer). Based on treatment the market is sub-segmented into protease inhibitors (pis), non-nucleoside reverse transcriptase inhibitors (nnrtis), nucleoside or nucleotide reverse transcriptase inhibitors (nrtis) entry or fusion inhibitors, integrase inhibitors, and others. based on end-user, the market is sub-segmented into diagnostic laboratories, hospitals, blood banks, home care settings, and other end users. The hospital segment is anticipated to grow at the fastest rate, as hospitals helps and provide accurate results to the patients under observation of experienced professional. Blood tests are the most common way to diagnose HIV. Most health care providers offer HIV testing, often with appropriate counseling. Anonymous and free testing also provided and during testing, doctor asks about symptoms, medical history and risk factors, and perform a physical examination and accordingly make a treatment plan that helps to fight HIV.


Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America dominates the market and is expected to continue its presence over the forecast period. The growth can be attributed to the increasing prevalence of injecting drugs by peoples Sharing needles, syringes, or other equipment (works) to inject drugs puts people at high risk for getting or transmitting HIV and other infections. According to CDC, syringe sharing is more common in young people. Around 48% of people aged 18 to 24 share syringes, 44% of people aged 25 to 29 share syringes. Most commonly, people get or transmit HIV through anal or vaginal sex, or sharing needles, syringes, or other drug injection equipment


The major companies serving the global HIV diagnostics & treatment market are GILEAD , GLAXOSMITHKLINE PLC. , HOLOGIC INC. , INC.(US), VIIV HEALTHCARE GROUP OF COMPANIES, JANSSEN DIAGNOSTICS and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in 2020 Gilead Sciences, Inc. and Merck have done agreement to co-develop and co-commercialize long-acting Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV. Merck and Gilead seek to build on their legacies of transforming HIV care by focusing on long-acting therapies, which may represent a meaningful innovation in HIV drug development.


Research Methodology

The market study of the global HIV diagnostics & treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.


Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.


Market Segmentation


  1. Global HIV diagnostics & treatment Market Research and Analysis by Test Type
  2. Global HIV diagnostics & treatment Market Research and Analysis by Diagnostic Product
  3. Global HIV diagnostics & treatment Market Research and Analysis by Treatment
  4. Global HIV diagnostics & treatment Market Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the global HIV diagnostics & treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global HIV diagnostics & treatment market.
  • Insights about market determinants that are stimulating the global HIV diagnostics & treatment market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the GlobalGlobal HIV diagnosis & treatmentMarket
  • Recovery Scenario of GlobalGlobal HIV diagnosis & treatmentMarket
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key CompanyAnalysis
3.1.1. QIAGEN
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. ROCHE DIAGNOSTICS
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. SIEMENS HEALTHCARE
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. SYSMEX CORPORATION
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. Sysmex Corp
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global HIV Diagnosis & Treatment Market, by Test type
4.1.1. Antibody Tests
4.1.2. Viral Identification Assays
4.1.3. CD4 Testing
4.1.4. Viral Load Testing
4.1.5. Early Infant Diagnostics
4.2. Global HIV Diagnosis & Treatment Market, by Diagnosis Product
4.2.1. Assays, Kits & Reagents
4.2.2. Instruments
4.2.3. Software & Service
4.2.4. Others
4.3. Global HIV Diagnosis & Treatment Market, by Treatment
4.3.1. Protease Inhibitors (PIS)
4.3.2. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)
4.3.3. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIS)
4.3.4. Entry or Fusion Inhibitors
4.3.5. Integrase Inhibitors
4.3.6. Others
4.4. Global HIV Diagnosis & Treatment Market, by End-user
4.4.1. Diagnostic Laboratories
4.4.2. Hospitals
4.4.3. Blood Banks
4.4.4. Home Care Settings
4.4.5. Other End Users
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott Laboratories
6.2. Boehringer Ingelheim Gmbh
6.3. Bristol-Myers Squibb Company
6.4. Cipla Inc.
6.5. F. Hoffmann-La Roche Ltd
6.6. Gilead
6.7. Glaxosmithkline Plc.
6.8. Hologic Inc.
6.9. Inc.(Us), Viiv Healthcare Group Of Companies
6.10. Janssen Diagnostics
6.11. Johnson & Johnson Services
6.12. Merck & Co. Inc.
6.13. Mylan Inc.
6.14. Sysmex Partec
6.15. Qiagen
6.16. Roche Diagnostics
6.17. Siemens Healthcare
6.18. Sysmex Corporation
List of Tables
1. Globalglobal Hiv Diagnosis & Treatmentmarket Research and Analysis Bytest Type2021-2028($ Million)
2. Globalantibody Tests in Hiv Diagnosis & Treatmentmarket Research and Analysis by Region, 2021-2028 ($ Million)
3. Global Viral Identification Assays in Hiv Diagnosis & Treatmentmarket Research and Analysis by Region, 2021-2028 ($ Million)
4. Globalcd4 Testing in Hiv Diagnosis & Treatmentmarket Research and Analysis Bydiagnostic Products2021-2028 ($ Million)
5. Global Viral Load Testing in Hiv Diagnosis & Treatmentmarket Research and Analysis by Region, 2021-2028 ($ Million)
6. Global Early Infant Diagnostics in Hiv Diagnosis & Treatmentmarket Research and Analysis by Region, 2021-2028 ($ Million)
7. Global Hiv Diagnosis & Treatment Platfrom Market Research and Analysis Bydiagnosis Product , 2021-2028 ($ Million)
8. Global Assays, Kits & Reagents in Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
9. Global Hiv Diagnosis & Treatmentinstrumentsmarket Research and Analysis by Region, 2021-2028 ($ Million)
10. Global Hiv Diagnosis & Treatmentsoftware & Servicemarket Research and Analysis by Region, 2021-2028 ($ Million)
11. Global Others Hiv Diagnosis & Treatmentmarket Research and Analysis by Treatment, 2021-2028 ($ Million)
12. Global Hiv Diagnosis & Treatment Platfrom Market Research and Analysis Bytreatment, 2021-2028 ($ Million)
13. Global Protease Inhibitors (Pis) for Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
14. Global Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis) for Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
15. Global Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (Nrtis) for Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
16. Global Entry or Fusion Inhibitors for Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
17. Global Integrase Inhibitors for Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
18. Global Other Test in Hiv Diagnosis & Treatment Market Research and Analysis by Region, 2021-2028 ($ Million)
19. Global Global Hiv Diagnosis & Treatment Market Research and Analysis by End-User, 2021-2028 ($ Million)
20. Global Global Hiv Diagnosis & Treatment Available in Diagnostic Laboratories Market Research and Analysis by Region, 2021-2028 ($ Million)
21. Global Global Hiv Diagnosis & Treatment Available in Hospitalsmarket Research and Analysis by Region, 2021-2028 ($ Million)
22. Global Global Hiv Diagnosis & Treatment Available in Blood Banksmarket Research and Analysis by Region, 2021-2028 ($ Million)
23. Global Global Hiv Diagnosis & Treatment Available Inhome Care Settings Market Research and Analysis by Region, 2021-2028 ($ Million)
24. Global Global Hiv Diagnosis & Treatment Available in Other End-Users Market Research and Analysis by Region, 2021-2028 ($ Million)
25. North Americanglobal Hiv Diagnosis & Treatmentmarket Research and Analysis by Country, 2021-2028 ($ Million)
26. North Americanglobal Hiv Diagnosis & Treatmentmarket Research and Analysis Bytest Type2021-2028 ($ Million)
27. North American Global Hiv Diagnosis & Treatmentmarket Research and Analysis Bydiagnostic Product, 2021-2028 ($ Million)
28. North American Global Hiv Diagnosis & Treatment Market Research and Analysis by Treatment, 2021-2028 ($ Million)
29. North American Global Hiv Diagnosis & Treatment Market Research and Analysis by End-User, 2021-2028 ($ Million)
30. Europeanglobal Hiv Diagnosis & Treatmentmarket Research and Analysis by Country, 2021-2028 ($ Million)
31. European Global Hiv Diagnosis & Treatmentmarket Research and Analysis Bytest Type2021-2028 ($ Million)
32. European Global Hiv Diagnosis & Treatmentmarket Research and Analysis Bydiagnostic Products2021-2028 ($ Million)
33. European Global Hiv Diagnosis & Treatment Market Research and Analysis by Treatment, 2021-2028 ($ Million)
34. European Global Hiv Diagnosis & Treatment Market Research and Analysis by End -User, 2021-2028 ($ Million)
35. Asia-Pacificglobal Hiv Diagnosis & Treatmentmarket Research and Analysis by Country, 2021-2028 ($ Million)
36. Asia-Pacificglobal Hiv Diagnosis & Treatmentmarket Research and Analysis Bytest Type2021-2028 ($ Million)
37. Asia-Pacific Global Hiv Diagnosis & Treatmentmarket Research and Analysis Bydiagnostic Products2021-2028 ($ Million)
38. Asia-Pacific Global Hiv Diagnosis & Treatment Market Research and Analysis by Treatment, 2021-2028 ($ Million)
39. Asia-Pacific Global Hiv Diagnosis & Treatment Market Research and Analysis by End-User, 2021-2028 ($ Million)
40. Rest of the Worldglobal Hiv Diagnosis & Treatmentmarket Research and Analysis by Country, 2021-2028 ($ Million)
41. Rest of the Worldglobal Hiv Diagnosis & Treatmentmarket Research and Analysis Bytest Type2021-2028 ($ Million)
42. Rest of the World Global Hiv Diagnosis & Treatmentmarket Research and Analysis Bydiagnostic Products2021-2028 ($ Million)
43. Rest of the World Global Hiv Diagnosis & Treatment Market Research and Analysis by Treatment, 2021-2028 ($ Million)
44. Rest of the World Global Hiv Diagnosis & Treatment Market Research and Analysis by End -User, 2021-2028 ($ Million)
List of Figures
1. Impact of Covid-19 on Globalglobal Hiv Diagnosis & Treatmentmarket, 2021-2028 ($ Million)
2. Impact of Covid-19 on Globalglobal Hiv Diagnosis & Treatmentmarket by Segment, 2021-2028 ($ Million)
3. Recovery of Globalglobal Hiv Diagnosis & Treatmentmarket, 2021-2028 (%)
4. Globalglobal Hiv Diagnosis & Treatmentmarket Share Bytest Type2021 Vs 2028 (%)
5. Global Antibody Tests in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
6. Global Viral Identification Assays in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
7. Global Cd4 Testing in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
8. Global Viral Load Testing in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
9. Global Early Infant Diagnostics in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
10. Global Hiv Diagnosis & Treatment Platfrom Market Research and Analysis by Diagnosis Product , 2021-2028 ($ Million)
11. Global Assays, Kits & Reagents in Hiv Diagnosis & Treatment Market Share by Region, 2021-2028 ($ Million)
12. Global Hiv Diagnosis & Treatment Instruments Market Share by Region 2021 Vs 2028 (%)
13. Global Hiv Diagnosis & Treatment Software & Service Market Share by Region 2021 Vs 2028 (%)
14. Global Others Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
15. Global Hiv Diagnosis & Treatment Platfrom Market Share by Region 2021 Vs 2028 (%)
16. Global Protease Inhibitors (Pis) for Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
17. Global Non-Nucleoside Reverse Transcriptase Inhibitors (Nnrtis) for Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
18. Global Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (Nrtis) for Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
19. Global Entry or Fusion Inhibitors for Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
20. Global Integrase Inhibitors for Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
21. Global Other Test in Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
22. Global Global Hiv Diagnosis & Treatment Market Share by Region 2021 Vs 2028 (%)
23. Global Global Hiv Diagnosis & Treatment Available in Diagnostic Laboratories Market Share by Region 2021 Vs 2028 (%)
24. Global Global Hiv Diagnosis & Treatment Available in Hospitals Market Share by Region 2021 Vs 2028 (%)
25. Global Global Hiv Diagnosis & Treatment Available in Blood Banks Market Share by Region 2021 Vs 2028 (%)
26. Global Global Hiv Diagnosis & Treatment Available in Home Care Settings Market Share by Region 2021 Vs 2028 (%)
27. Global Global Hiv Diagnosis & Treatment Available in Other End-Users Market Share by Region 2021 Vs 2028 (%)
28. Us Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
29. Canada Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
30. Ukglobal Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
31. France Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
32. Germany Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
33. Italy Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
34. Spain Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
35. Rest of Europe Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
36. India Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
37. Chinaglobal Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
38. Japan Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
39. South Korea Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
40. Rest of Asia-Pacific Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)
41. Rest of the World Global Hiv Diagnosis & Treatmentmarket Size, 2021-2028 ($ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • F. Hoffmann-La Roche Ltd
  • Gilead
  • Glaxosmithkline Plc.
  • Hologic Inc.
  • Inc.(Us), Viiv Healthcare Group Of Companies
  • Janssen Diagnostics
  • Johnson & Johnson Services
  • Merck & Co. Inc.
  • Mylan Inc.
  • Sysmex Partec
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex Corporation